LaminarPace, Ziccum’s unique drying and formulation technology for biologics, has been featured in “Spray Drying of Vaccines – from Laboratory Research to Industrial Applications” by Dr. Cordin Arpagaus. The book argues that emerging alternative drying technologies like LaminarPace are paving the way for enhanced thermostability and dose delivery possibilities
With exciting evidence and compelling cases, “Spray Drying of Vaccines – from Laboratory Research to Industrial Applications” by Dr. Cordin Arpagaus, argues that new advances in aseptic spray drying technologies represent a paradigm shift for vaccine production. In the book an early iteration of LaminarPace is featured in Chapter 3, “Drying Technologies for Vaccines”.
LaminarPace is unique amongst formulation and drying technologies for biologics. Its Mass Transfer drying technique is able to transform delicate liquid vaccine solutions into stable, bioactive dry powder – without exposing them to extreme temperatures, stress factors or degradation. This sets it apart from legacy pharmaceutical drying systems such as lyophilization (freeze drying).
Read more about our Mass Transfer drying technology here.